Division of Cardiology, Showa University Fujigaoka Rehabilitation Hospital, Yokohama, Japan; Showa University Research Institute for Sport and Exercise Sciences, Yokohama, Japan.
Division of Cardiology, Showa University Fujigaoka Rehabilitation Hospital, Yokohama, Japan; Division of Cardiology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Heart Lung Circ. 2021 Sep;30(9):1320-1328. doi: 10.1016/j.hlc.2021.03.268. Epub 2021 Apr 16.
Early reported beneficial effects of cardiac rehabilitation (CR) have recently been disputed. The present study aimed to investigate the clinical impact of CR on the mid-term outcomes of patients following ST-segment elevation myocardial infarction (STEMI) treated with currently available management.
This study reviewed 145 consecutive patients who underwent primary coronary intervention and were discharged without any disability after STEMI during 2013-2015.
Among the patients, 66 (45.5%) completed an outpatient CR program (CR group) and 79 were their non-CR counterparts or patients who dropped out of the program (N-D group). There were no between-group differences in patient demographics and clinical profiles, including door-to-balloon times and prescriptions. A total of 27 patients developed major adverse cardiac and cerebrovascular events (MACCE) during follow-up. The MACCE-free survival rates were 88% and 76% in the CR and N-D groups, respectively (log-rank, p=0.04). Cox proportional analysis demonstrated that inclusion in the N-D group was a significant predictor of MACCEs (HR, 2.36; 95% CI, 1.07-5.74; p=0.03). In the CR group, peak oxygen consumption and ventilatory efficiency determined by cardiopulmonary exercise testing significantly improved after the program (p<0.01).
The impact of CR on the mid-term prognosis of patients with STEMI, even in the current myocardial infarction management era, was beneficial.
心脏康复(CR)早期报告的有益效果最近受到质疑。本研究旨在调查 CR 对接受目前可用管理的 ST 段抬高型心肌梗死(STEMI)患者中期结局的临床影响。
本研究回顾了 2013 年至 2015 年间连续接受初次经皮冠状动脉介入治疗且 STEMI 后出院时无任何残疾的 145 例患者。
患者中,66 例(45.5%)完成了门诊 CR 项目(CR 组),79 例为非 CR 患者或退出项目的患者(N-D 组)。两组患者的人口统计学和临床特征,包括门球时间和处方,均无差异。随访期间共有 27 例患者发生主要不良心脑血管事件(MACCE)。CR 组和 N-D 组的 MACCE 无事件生存率分别为 88%和 76%(log-rank,p=0.04)。Cox 比例风险分析表明,纳入 N-D 组是 MACCE 的显著预测因素(HR,2.36;95%CI,1.07-5.74;p=0.03)。在 CR 组中,心肺运动试验测定的峰值耗氧量和通气效率在项目后显著改善(p<0.01)。
即使在目前的心肌梗死管理时代,CR 对 STEMI 患者的中期预后也有益。